In addition, KEGG analysis of candidate targets disclosed that fucosterol probably has therapeutic effect on NSCLC through multiple pathways like PI3K-Akt signaling pathway, VEGF signaling pathway, ErbB signaling pathway. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.